Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease (Q64060972)

1

0 references

Willem Luytjes

2

0 references

Gerben Ferwerda

3

0 references

Puck B van Kasteren

Creative Commons Attribution 4.0 International

4

0 references

language of work or name

English

0 references

publication date

2019

0 references

22 March 2019

2 references

23 October 2022

28 October 2022

Frontiers in Immunology

2 references

23 October 2022

28 October 2022

10

0 references

page(s)

548

0 references

copyright license

2 references

Europe PubMed Central

23 October 2022

Europe PubMed Central

Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties

28 October 2022

cites work

1 reference

12 December 2020

Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus

1 reference

12 December 2020

Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG

1 reference

12 December 2020

Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function

1 reference

12 December 2020

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

1 reference

12 December 2020

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

1 reference

12 December 2020

Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice

1 reference

12 December 2020

Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity

1 reference

12 December 2020

Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived

1 reference

12 December 2020

Molecular basis for a polymorphism of human Fc gamma receptor II (CD32)

1 reference

12 December 2020

IgG subclass distribution of antibodies to bacterial and viral antigens

1 reference

12 December 2020

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

12 December 2020

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

12 December 2020

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

1 reference

12 December 2020

Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections

1 reference

12 December 2020

Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

1 reference

12 December 2020

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus

1 reference

12 December 2020

Ontogenesis of the formation of secretory antibodies to respiratory syncytial (RS) virus

1 reference

12 December 2020

Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.

1 reference

12 December 2020

Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.

1 reference

12 December 2020

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

1 reference

12 December 2020

1 reference

12 December 2020

Complement Fixation on Cell Surfaces by 19 S and 7 S Antibodies

1 reference

12 December 2020

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

1 reference

12 December 2020

Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease

1 reference

12 December 2020

Crossed immunoelectrophoresis for the detection of split products of the third complement in dengue hemorrhagic fever. I. Observations in patients' plasma

1 reference

12 December 2020

Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus

1 reference

12 December 2020

Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus

1 reference

12 December 2020

Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus

1 reference

12 December 2020

Effect of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophils

1 reference

12 December 2020

The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection

1 reference

12 December 2020

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

1 reference

12 December 2020

Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials

1 reference

12 December 2020

Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease

1 reference

12 December 2020

Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes

1 reference

12 December 2020

Antibody responses of children to the C-terminal peptide of the SH protein of respiratory syncytial virus and the immunological characterization of this protein

1 reference

12 December 2020

The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years

1 reference

12 December 2020

Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections.

1 reference

12 December 2020

Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.

1 reference

12 December 2020

Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.

1 reference

12 December 2020

HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression

1 reference

12 December 2020

Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.

1 reference

12 December 2020

An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus

1 reference

12 December 2020

Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype

1 reference

12 December 2020

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection

1 reference

12 December 2020

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

1 reference

12 December 2020

SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis

1 reference

12 December 2020

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

12 December 2020

Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production.

1 reference

12 December 2020

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

1 reference

12 December 2020

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

12 December 2020

Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors.

1 reference

12 December 2020

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

12 December 2020

Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.

1 reference

12 December 2020

A role for immune complexes in enhanced respiratory syncytial virus disease

1 reference

12 December 2020

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

1 reference

12 December 2020

Activation of NK cell cytotoxicity

1 reference

12 December 2020

Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells

1 reference

12 December 2020

Respiratory syncytial virus and neutrophil activation

1 reference

12 December 2020

Immune responses and disease enhancement during respiratory syncytial virus infection

1 reference

12 December 2020

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

1 reference

12 December 2020

Fcgamma receptors: old friends and new family members

1 reference

12 December 2020

Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein

1 reference

12 December 2020

Antibodies from patients with dengue viral infection mediate cellular cytotoxicity

1 reference

12 December 2020

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

1 reference

12 December 2020

C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.

1 reference

12 December 2020

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

1 reference

12 December 2020

Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program

1 reference

12 December 2020

Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple

1 reference

12 December 2020

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes

1 reference

12 December 2020

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

12 December 2020

Lower respiratory tract infection caused by respiratory syncytial virus in infants: the role played by specific antibodies.

1 reference

12 December 2020

The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease

1 reference

12 December 2020

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

12 December 2020

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

1 reference

12 December 2020

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

1 reference

12 December 2020

Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice

1 reference

12 December 2020

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

1 reference

12 December 2020

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze

1 reference

12 December 2020

The burden of respiratory syncytial virus infection in young children

1 reference

12 December 2020

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

1 reference

12 December 2020

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

1 reference

12 December 2020

Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response.

1 reference

12 December 2020

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice

1 reference

12 December 2020

Functional and clinical consequences of Fc receptor polymorphic and copy number variants.

1 reference

12 December 2020

Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity

1 reference

12 December 2020

Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus

1 reference

12 December 2020

Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.

1 reference

12 December 2020

Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

1 reference

12 December 2020

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

1 reference

12 December 2020

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

1 reference

12 December 2020

Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer

1 reference

12 December 2020

Complement-dependent transport of antigen into B cell follicles

1 reference

12 December 2020

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

1 reference

12 December 2020

Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.

1 reference

12 December 2020

Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.

1 reference

12 December 2020

Preclinical studies on the mechanism of action and the anti-lymphoma activity of the novel anti-CD20 antibody GA101.

1 reference

12 December 2020

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

1 reference

12 December 2020

One target, different effects: a comparison of distinct therapeutic antibodies against the same targets

1 reference

12 December 2020

Role of macrophages in early protective immune responses induced by two vaccines against foot and mouth disease

1 reference

12 December 2020

Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms

1 reference

12 December 2020

Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins

1 reference

12 December 2020

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

1 reference

12 December 2020

Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection

1 reference

12 December 2020

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

1 reference

12 December 2020

Antibody therapy of cancer

1 reference

12 December 2020

BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway

1 reference

12 December 2020

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

12 December 2020

The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

1 reference

12 December 2020

Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination

1 reference

12 December 2020

CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin

1 reference

12 December 2020

CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection

1 reference

12 December 2020

Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection

1 reference

12 December 2020

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer

1 reference

12 December 2020

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

1 reference

12 December 2020

Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection

1 reference

12 December 2020

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

1 reference

12 December 2020

Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease

1 reference

12 December 2020

Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys

1 reference

12 December 2020

Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies

1 reference

12 December 2020

Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein

1 reference

12 December 2020

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

1 reference

12 December 2020

Targeting the Fc receptor in autoimmune disease

1 reference

12 December 2020

Complement is activated by IgG hexamers assembled at the cell surface

1 reference

12 December 2020

Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines

1 reference

12 December 2020

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy

1 reference

12 December 2020

Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh

1 reference

12 December 2020

Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice

1 reference

12 December 2020

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial

1 reference

12 December 2020

Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in childre

1 reference

12 December 2020

Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity

1 reference

12 December 2020

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein

1 reference

12 December 2020

IgG subclasses and allotypes: from structure to effector functions

1 reference

12 December 2020

Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review

1 reference

12 December 2020

Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

1 reference

12 December 2020

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice

1 reference

12 December 2020

IgE anti-respiratory syncytial virus antibodies detected in serum of pediatric patients with asthma

1 reference

12 December 2020

Complement System Part II: Role in Immunity

1 reference

12 December 2020

Complement System Part I - Molecular Mechanisms of Activation and Regulation

1 reference

12 December 2020

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

1 reference

12 December 2020

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

1 reference

12 December 2020

NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation.

1 reference

12 December 2020

A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus

1 reference

12 December 2020

Antibodies enhance CXCL10 production during RSV infection of infant and adult immune cells

1 reference

12 December 2020

Single nucleotide polymorphisms in immune system genes and their association with clinical symptoms persistence in dengue-infected persons.

1 reference

12 December 2020

Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells

1 reference

12 December 2020

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

1 reference

12 December 2020

Immune correlates of vaccine protection against HIV-1 acquisition

1 reference

12 December 2020

The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease

1 reference

12 December 2020

Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity

1 reference

12 December 2020

Fc receptors in antibody-dependent enhancement of viral infections

1 reference

12 December 2020

Interleukin-15 is associated with disease severity in viral bronchiolitis

1 reference

12 December 2020

Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development

1 reference

12 December 2020

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures

1 reference

12 December 2020

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

1 reference

12 December 2020

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

1 reference

12 December 2020

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

1 reference

12 December 2020

Influenza-Specific Antibody-Dependent Phagocytosis

1 reference

12 December 2020

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

1 reference

12 December 2020

NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice

1 reference

12 December 2020

Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors

1 reference

12 December 2020

Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge

1 reference

12 December 2020

Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis

1 reference

12 December 2020

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

1 reference

12 December 2020

A Functional Role for Antibodies in Tuberculosis

1 reference

12 December 2020

Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection

1 reference

12 December 2020

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

1 reference

12 December 2020

Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function.

1 reference

12 December 2020

Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity and influenza virus

1 reference

12 December 2020

Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection

1 reference

12 December 2020

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

1 reference

12 December 2020

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

1 reference

12 December 2020

Systems serology for evaluation of HIV vaccine trials

1 reference

12 December 2020

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

1 reference

12 December 2020

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age

1 reference

12 December 2020

Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant

1 reference

12 December 2020

Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.

1 reference

12 December 2020

Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection

1 reference

12 December 2020

Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice

1 reference

12 December 2020

The Immunoregulatory Roles of Antibody Glycosylation

1 reference

12 December 2020

Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms.

1 reference

12 December 2020

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

1 reference

12 December 2020

Fc functional antibodies in humans with severe H7N9 and seasonal influenza

1 reference

12 December 2020

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

1 reference

12 December 2020

In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.

1 reference

12 December 2020

Fcγ Receptor Function and the Design of Vaccination Strategies.

1 reference

12 December 2020

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

1 reference

12 December 2020

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal

1 reference

12 December 2020

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

1 reference

12 December 2020

An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

1 reference

12 December 2020

Prefusion F, postfusion F, G antibodies and disease severity in infants and young children with acute respiratory syncytial virus infection

1 reference

12 December 2020

Antibody-dependent enhancement of severe dengue disease in humans.

1 reference

12 December 2020

Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.

1 reference

12 December 2020

Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4+T cells Immune Responses

1 reference

12 December 2020

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination.

1 reference

12 December 2020

Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies.

1 reference

12 December 2020

Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.

1 reference

12 December 2020

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.

1 reference

12 December 2020

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

1 reference

12 December 2020

Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets.

1 reference

12 December 2020

A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus

1 reference

12 December 2020

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

1 reference

12 December 2020

Respiratory syncytial virus (RSV) infects primary neonatal and adult natural killer cells and affects their anti-viral effector function

1 reference

12 December 2020